| scholarly article | Q13442814 |
| P2093 | author name string | Arzimanoglou II | |
| Gilbert F | |||
| Osborne M | |||
| Barber H | |||
| Lallas T | |||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ovarian cancer | Q172341 |
| P304 | page(s) | 1799-1804 | |
| P577 | publication date | 1996-09-01 | |
| P1433 | published in | Carcinogenesis | Q326022 |
| P1476 | title | Microsatellite instability differences between familial and sporadic ovarian cancers | |
| P478 | volume | 17 |
| Q36643443 | A change in microsatellite instability caused by cisplatin-based chemotherapy of ovarian cancer |
| Q78141327 | Allelic imbalance in chromosome band 18q21 and SMAD4 mutations in ovarian cancers |
| Q58213050 | Allelic imbalance in selected chromosomal regions in ovarian cancer |
| Q73428250 | Are DNA mismatch repair deficiencies responsible for accumulation of genetic alterations in epithelial ovarian cancers? |
| Q37040968 | Clinical significance of microsatellite instability in sporadic epithelial ovarian tumors. |
| Q74137972 | Comprehensive analysis of 112 melanocytic skin lesions demonstrates microsatellite instability in melanomas and dysplastic nevi, but not in benign nevi |
| Q73263789 | DNA replication error is frequent in ovarian granulosa cell tumors |
| Q73506437 | DNA replication errors are frequent in mucinous cystadenocarcinoma of the ovary |
| Q35023943 | Frequency of mismatch repair deficiency in ovarian cancer: a systematic review This article is a US Government work and, as such, is in the public domain of the United States of America |
| Q35848850 | Genetic pathways to melanoma tumorigenesis |
| Q80186521 | Immunohistochemical staining of hMLH1 and hMSH2 reflects microsatellite instability status in ovarian carcinoma |
| Q36784982 | Loss of DNA mismatch repair protein hMSH6 in ovarian cancer is histotype-specific |
| Q74448774 | Loss of heterozygosity, microsatellite instability, and mismatch repair protein alterations in the radial growth phase of cutaneous malignant melanomas |
| Q34723085 | Microsatellite instability and its relevance to cutaneous tumorigenesis |
| Q77931531 | Microsatellite instability in European hepatocellular carcinoma |
| Q34527738 | Microsatellite instability in human melanocytic skin tumors: an incidental finding or a pathogenetic mechanism? |
| Q73515289 | Microsatellite instability in ovarian and other pelvic carcinomas |
| Q73758307 | Microsatellite instability in squamous cell carcinoma of head and neck from the Indian patient population |
| Q33252378 | Mismatch repair and treatment resistance in ovarian cancer |
| Q44644581 | Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma. |
| Q35758048 | Molecular mechanisms of resistance and toxicity associated with platinating agents |
| Q58325249 | Mutations in a 10-bp polyadenine repeat of transforming growth factor β-receptor type II gene is an infrequent event in human epithelial ovarian cancer |
| Q24531843 | No significant role for beta tubulin mutations and mismatch repair defects in ovarian cancer resistance to paclitaxel/cisplatin |
| Q37147224 | Sampling strategies for tissue microarrays to evaluate biomarkers in ovarian cancer |
| Q81637142 | The contribution of the hereditary nonpolyposis colorectal cancer syndrome to the development of ovarian cancer |
| Q37347191 | Tumor spreading to the contralateral ovary in bilateral ovarian carcinoma is a late event in clonal evolution |
| Q36620488 | hMSH2 and GTBP expression in advanced stage epithelial ovarian cancer. |
Search more.